Blood test may predict implant scarring after breast cancer radiation
NCT ID NCT04342546
First seen Apr 24, 2026 · Last updated Jun 20, 2026 · Updated 9 times
Summary
This study is testing a blood test called NovaGray RILA Breast® to see if it can predict severe capsular contracture (hardening and tightening of scar tissue around a breast implant) after radiotherapy. Researchers will enroll 250 breast cancer patients who have had a mastectomy with immediate implant reconstruction and need chest wall radiation. The test is done before and after radiotherapy, and its accuracy will be compared to actual outcomes over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Georges François Leclerc
RECRUITINGDijon, 21079, France
Contact Email: •••••@•••••
-
Centre Léon Bérard
RECRUITINGLyon, 69373, France
Contact Email: •••••@•••••
-
Centre Oscar Lambret
RECRUITINGLille, 59000, France
Contact Email: •••••@•••••
-
Hôpital Tenon
RECRUITINGParis, 75970, France
Contact Email: •••••@•••••
-
Institut Claudius Regaud
RECRUITINGToulouse, 31059, France
Contact Email: •••••@•••••
-
Institut Paoli Calmette
RECRUITINGMarseille, 13009, France
Contact Email: •••••@•••••
-
Institut de Cancérologie de l'Ouest
RECRUITINGSaint-Herblain, 44805, France
Contact Email: •••••@•••••
-
Institut du Cancer de Montpellier
RECRUITINGMontpellier, 34298, France
Contact Email: •••••@•••••
-
centre Antoine Lacassagne
RECRUITINGNice, 06189, France
Contact Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NovaGray RILA Breast® test (blood test)
What this could lead to
If successful, this test could help doctors identify patients at high risk for severe capsular contracture before radiotherapy, allowing personalized treatment planning.
What could go wrong
This is an early-stage diagnostic study, not a treatment trial. The test may not accurately predict toxicity in all patients, and results may not change outcomes.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.